drugset / Trial / NCT01211431
Post-cesarean Pain Control Via Continuous Infusion of Ropivacain et Diclogenac Into the Wound Versus Intathecal Morphine
RandomizedParallel-groupOpen-labelTreatment
Summary
The goal is to compare the quality of post-cesarean analgesia, the side effects and the incidence of residual scar pain obtained with intrathecal morphine (reference treatment) or with a continuous intra-wound solution including both ropivacain and diclofenac (experimental treatment).
Timeline
- Start
- 2010-09
- Primary completion
- 2012-10
- Completion
- 2012-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Diclofenac | Other / unclassified | — | Other |
| Subject | Morphine | Other / unclassified | — | Intrathecal |
| Subject | Ropivacaine | Other / unclassified | — | Other |
Indications
No indication recorded.